Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by 2b7f6fabon Jul 14, 2017 11:12pm
232 Views
Post# 26472100

RE:Roger's Dilemma

RE:Roger's DilemmaThat's nothing, it gets worse.  I've heard that every brokerage account holding TLT will be assessed an additional 10 cents per share.  Out of that ten cents a nickle will go to resettle Sudanese rapeugees to the Northwest Territories, the Nunavet, and Quebec. Another 2 cents will be allocated to inner city mid-night basketball leagues..  The rest will go to cultural projects like erecting shrines to John Candy, Pamela Anderson, Rachel McAdams.


Mark71cl wrote:
Mickey2 wrote,"Please DO NOT release any data/information.  It would be wasted. There is a private placement coming.  Release the data after the pp is announced.".

.RW has already run out of money per the Dec 2016 to Mar31 2017 burn rate which is public record.
Now he has to explain the pp offering at very bad terms to the shareholders.  As has been evident by the Ontario Securities personnel, he can no longer provide the pie in the sky timelines that were used to goose the stock price in prior years This is evident to anyone who read the nr's from 2014.  I think you'll likely be able to enter tlt at under $0.30 within the next 30 days as RW had to start finalizing this pp in late June...the pp deal has already been made with the finishing financing details nearly complete..

A side note: In 2015 when it became evident that RW was not meeting his timelines Bencro was there then too. Today he's talking about prostate cancer and tomorrow it will be the next great tlt endeavor. Never focusing on the status of the trial at hand. For those around in 2015, it was the laser that was gonna fund the cancer trials. Bencro would publish nonsense about the laser stimulating hair growth for bald men or its potential use in Brazil on plastic surgery to reduce breast implant scarring (no I'm not making this up). Bencro has always been the band leader trying to play the next tune when we've not finished the tune at hand. Should be interesting to see how he spins the pp when announced shortly. Do your homework and read what these guys said in the past..  


Bullboard Posts